Search Blog
Categories
December 2013
M T W T F S S
« Nov   Jan »
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Tags

Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners

admin

By PrimeTimeMedia LLC

New York, December 05 , 2013 /Accesswire/ – Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Citigroup Inc(NYSE:C), Market Vectors Gold Miners ETF(NYSE:GDX), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).

Citigroup
Inc(NYSE:C) shares declined 0.77% to $51.64 in the pre-market hour. Citi and
American Airlines on Dec. 4 announced that beginning in March 2014, the Citi®
Executive® / AAdvantage® World Elite MasterCard® will be the only U.S. credit
card offering full membership benefits at the American Airlines Admirals Club®
airport lounges.

Free Urgent Insider Catalyst Report For C Available Here:  http://marketbuzzreport.com/index.php?code=C (Or Copy and paste the URL into your browser)

Additionally, John Gerspach, Chief Financial Officer of Citigroup, will present at the Goldman Sachs 2013 Financial Services Conference on Tuesday, December 10, 2013. The presentation is expected to begin at approximately 12:30 PM (Eastern). A live webcast will be available at www.citigroup.com/citi/investor. A replay and transcript of the webcast will be available shortly after the event.

Market Vectors Gold Miners ETF(NYSEARCA:GDX) shares decreased 2.69% to $20.65 in the pre-market hour. The 52 week trading range for the company is $20.57 – $47.96. GDX seeks to replicate as closely as possible the price and yield performance of NYSE Arca Gold Miners Index (GDM). GDM is a market capitalization-weighted index, and provides exposure to publicly traded companies worldwide involved primarily in gold mining, representing a diversified blend of small-, mid- and large capitalization stocks.

Free Urgent Insider Catalyst Report For GDX Available Here:  http://marketbuzzreport.com/index.php?code=GDX (Or Copy and paste the URL into your browser)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock fell 1.23% to $6.53 in the pre-market hour. Eisai Inc. and Arena Pharmaceuticals on Nov. 18 announced that a new data analysis from the BELVIQ® (lorcaserin HCl) Phase 3 clinical trial program will be presented at the American Heart Association 2013 Scientific Sessions, November 16-20 in Dallas, Texas.

Free Urgent Insider Catalyst Report For ARNA Available Here:  http://marketbuzzreport.com/index.php?code=ARNA (Or Copy and paste the URL into your browser)

Additionally, the company presented a corporate overview at the 25th Annual Piper Jaffray Healthcare Conference on Dec. 4 at 11:30 a.m. E.T. at The New York Palace Hotel in NY City.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares increased 0.21% to $4.85 in the pre-market hour. The company on Dec. 3 announced the schedule of several data presentations on Iclusig® (ponatinib) that will take place at the 55th Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, December 7 to 10, 2013. 

Free Urgent Insider Catalyst Report For ARIA Available Here:  http://Marketbuzzreport.Com/Index.Php?Code=ARIA (Or Copy and paste the URL into your browser)  

Additionally, Labaton Sucharow LLP on Dec. 3 filed a class action lawsuit on December 3, 2013 in the U.S. District Court for the District of Massachusetts. The lawsuit was filed on behalf of persons who purchased, otherwise acquired, or contracted to acquire securities of Ariad Pharmaceuticals, Inc. (“Ariad” or the “Company”) (ARIA) between December 12, 2011 and October 8, 2013, inclusive (the “Class Period”). 

If you purchased, acquired, or contracted to acquire Ariad securities during the Class Period, you may be able to seek appointment as Lead Plaintiff. Lead Plaintiff motion papers must be filed with the U.S. District Court for the District of Massachusetts no later than December 9, 2013.  

USMarketBuzz.com is an investment community that focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/

Follow us on Facebook: https://www.facebook.com/usmarket.buzz.

Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126 (SMS alerts are free, however data rates may apply, check your wireless plan for details.).